PCM
SGFY

Prelude Capital Management’s Signify Health, Inc. SGFY Stock Holding History

Prelude Capital Management’s Portfolio SGFY Stock Details SGFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-89,344
Closed -$2.56M – 1622
2022
Q4 		$2.56M Sell
89,344
-156,997
-64% -$4.53M 0.13% 175
2022
Q3 		$7.18M Buy
+246,341
New +$5.67M 0.26% 51

Other funds holding SGFY

BHCM
Brevan Howard Capital Management St. Helier, Jersey $11.3B AUM 35.84% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
FCA
FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Prelude Capital Management's SGFY Position: Q1 2023 in Review

Prelude Capital Management sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 89,344 shares — an estimated $2.56M sold.

Prelude Capital Management first reported a position in SGFY in Q3 2022 and held it in 2 quarters. The position peaked at $7.18M in Q3 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Prelude Capital Management reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 89,344 Signify Health, Inc. shares in Q1 2023, an estimated $2.56M.
  • Prelude Capital Management first reported a position in Signify Health, Inc. in Q3 2022 and held it in 2 quarters.
  • Prelude Capital Management's Signify Health, Inc. position peaked at $7.18M in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.